About Chempro Pharma
Chempro Pharma is a Healthcare company based in Mumbai (India) founded in 2001, and was acquired by Hextar Global in March 2021. It operates as an APIs are manufactured and formulations are contract-produced by Chempro Pharma. Its chief executive is Arun Sehgal. Its Indian entity Chempro Pharma Private Limited reported revenue of ₹37.02 Cr. Chempro Pharma offers products and services including APIs, Finished Formulations, Critical Raw Materials, Specialty Chemicals, and Healthcare Devices Distribution. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Chempro Pharma was founded in 2001 in Mumbai, India, as a manufacturer of active pharmaceutical ingredients and formulations. Operations include production for the domestic market and exports to Japan, China, Indonesia, North America, Latin America, and the African sub-continent. Contract manufacturing services are provided to companies such as Pfizer, GlaxoSmithKline, Ranbaxy, Dr. Reddys, Abbott, Merck, and Novartis.
- Headquarters Mumbai, India
- Stage Acquired
- SectorsHealthcare
- Website chemprogroup.com/pharma/index.html
- Social LinkedIn
- Acquired by Hextar Global (Mar 2021)
- Legal Name Chempro Pharma Private Limited
- Date of Incorporation 17 May, 2008
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹37.02 Cr
FY 2025 · -12% YoY
- Net Profit₹43.4 Lakh
FY 2025 · 1% margin
- EBITDA₹84.8 Lakh
FY 2025 · 2% margin
- Investors
- Acquired byHextar Global
(Mar 2021)
Associated legal entities of Chempro Pharma
Chempro Pharma operates through Chempro Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Chempro Pharma Private Limited CIN U24230MH2008PTC182363 | Active | 17 May 2008 | Mumbai, Maharashtra | ₹37.0 Cr | – | 5 | View details |
Products & Services of Chempro Pharma
Chempro Pharma offers a comprehensive portfolio of products and services, including APIs, Finished Formulations, Critical Raw Materials, Specialty Chemicals, and Healthcare Devices Distribution.
Manufacture and export of active pharmaceutical ingredients for drugs.
Production of ready-to-use drug formulations for global markets.
Supply of essential raw materials for pharmaceutical production.
Development and export of fine chemicals and dyes for industries.
Platform for distributing global healthcare devices in India.
Investors in Chempro Pharma
Chempro Pharma has secured backing from 1 investor. Prominent investors backing the company include Hextar Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment holding company distributing agrochemicals, energy solutions, and industrial products. | 2019 | hextarglobal.com | Klang, Malaysia |
Investor details for Chempro Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Chempro Pharma Private Limited (Chempro Pharma)
Chempro Pharma Private Limited is the primary company behind Chempro Pharma. The board of Chempro Pharma Private Limited currently have 5 directors; the longest-serving is Arun Sehgal, appointed in 2008. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arun Sehgal DIN 00491163 | Director | 17 May 2008 | 18 yrs 5 mo | Chempro Pharma Private Limited |
| Vijay Shyamsunder Agarwal DIN 00491451 | Director | 17 May 2008 | 18 yrs 5 mo | Chempro Pharma Private Limited |
| Deepkiran Shantaram Khanwalkar DIN 02352272 | Director | 18 Dec 2009 | 16 yrs 10 mo | Chempro Pharma Private Limited |
| Vandan Vijay Agarwal DIN 02286171 | Director | 03 Apr 2023 | 3 yrs 6 mo | Chempro Pharma Private Limited |
| Shubhit Arun Sehgal DIN 08964524 | Additional Director | 12 Mar 2025 | 1 yr 7 mo | Chempro Pharma Private Limited |
People of Chempro Pharma
1 people are tracked at Chempro Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO & President | Leadership |
Complete people profiles for Chempro Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Chempro Pharma
Figures of Chempro Pharma Private Limited, the primary company behind Chempro Pharma, for FY 2025. Revenue was ₹37.02 Cr (-12% year on year). Net profit was ₹43.4 Lakh (1% margin). EBITDA was ₹84.8 Lakh (2% margin). Revenue has grown at a compounded annual rate of +21% over three years and +9% over five years.
- ₹37.02 CrRevenue · FY 2025 · -12% YoY
- ₹43.4 LakhNet profit · 1% margin
- ₹84.8 LakhEBITDA · 2% margin
- ₹1.2 LakhPaid-up capital
- +21%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Chempro Pharma Private Limited are on its company page.
Detailed financial statements for Chempro Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Chempro Pharma
2 dated milestones of Chempro Pharma across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Chempro Pharma is founded.
- Exit Acquired by Hextar Global.
Competitors of Chempro Pharma
Chempro Pharma has 10 listed competitors in our database, 4 of them funded. They include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | – | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | – | Contract research and development services for small molecules are offered. |
Detailed competitors of Chempro Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Chempro Pharma
The website of Chempro Pharma (chemprogroup.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 23.1% vs previous month
Websites whose visitors overlap most with Chempro Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| coreyorganics.com | 100% | 1.2K | #10,889,995 | View details | |
| vineetlabs.co.in | 98% | – | – | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Chempro Pharma (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chempro Pharma
Complete news archive for Chempro Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chempro Pharma
Chempro Pharma was founded in 2001.
Chempro Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Arun Sehgal is the current CEO of Chempro Pharma.
The primary company behind Chempro Pharma, Chempro Pharma Private Limited, reported revenue of ₹37.02 Cr for FY 2025, down 12% year on year.
Chempro Pharma was founded in 2001 in Mumbai, India, as a manufacturer of active pharmaceutical ingredients and formulations. Operations include production for the domestic market and exports to Japan, China, Indonesia, North America, Latin America, and the African sub-continent. Contract manufacturing services are provided to companies such as Pfizer, GlaxoSmithKline, Ranbaxy, Dr. Reddys, Abbott, Merck, and Novartis.
Chempro Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Chempro Pharma offers APIs, Finished Formulations, Critical Raw Materials, Specialty Chemicals, and Healthcare Devices Distribution.
Chempro Pharma has 1 investor. Key investors include Hextar Global.
Chempro Pharma operates through Chempro Pharma Private Limited.
Yes. Chempro Pharma was acquired by Hextar Global in March 2021.
The legal entities of Chempro Pharma currently have 5 directors, including Deepkiran Shantaram Khanwalkar, Shubhit Arun Sehgal, Arun Sehgal and others.